This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Zacks.com featured highlights include: MEDIFAST, Hanger, Netlist, North American Construction and MiX Telematics
by Zacks Equity Research
Zacks.com featured highlights include: MEDIFAST, Hanger, Netlist, North American Construction and MiX Telematics
Smucker's (SJM) Stock Down on Q1 Earnings Miss & View Cut
by Zacks Equity Research
J.M. Smucker's (SJM) first-quarter results are hurt by unfavorable shipment timings, competition in the premium dog food business, and lower pricing in coffee and peanut butter businesses.
Go Beyond Bargain Hunting: Tap 5 Stocks With Rising P/E
by Sanghamitra Saha
Bet on these top-ranked stocks with rising P/E to realize outsized gains.
General Mills (GIS) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
General Mills (GIS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
4 Reasons Why General Mills' (GIS) Stock is Worth a Shot Now
by Zacks Equity Research
General Mills (GIS) is on track with its key global growth strategies and cost-saving efforts. Blue Buffalo's inclusion is also yielding results.
Medifast (MED) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Medifast (MED) delivered earnings and revenue surprises of 2.34% and 3.03%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
3 Food Companies Likely to Top Estimates This Earnings Season
by Zacks Equity Research
Though high input costs are a concern for food companies, a few are likely to gain from prudent savings and brand-augmenting efforts.
Can Medifast (MED) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
Medifast (MED) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Medifast (MED) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Medifast (MED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Constellation Brands (STZ) Q1 Earnings & Sales Beat Estimates
by Zacks Equity Research
Constellation Brands (STZ) posts robust first-quarter fiscal 2020 results Moreover, the company updates outlook for the fiscal year.
United Natural Down 37% in 3 Months: Is a Revival Likely?
by Zacks Equity Research
United Natural (UNFI) benefits from prudent buyouts and other efficiency boosting plans. However, it is grappling with dismal gross margin and higher labor cost.
Two Food Stocks to Buy After General Mills (GIS) Posts Weak Q4 Sales
by Christopher Vargas
General Mills (GIS) reported their fourth quarter earnings today before the opening bell.
Archer Daniels Down 12% in a Year: Can Efforts Revive Stock?
by Zacks Equity Research
Archer Daniels' (ADM) soft Carbohydrate Solutions segment is concerning. Nevertheless, the company's growth efforts such as the Readiness program are commendable.
Zacks.com featured highlights include: Medifast, Shoe Carnival, Marine Products, Amedisys and NVR
by Zacks Equity Research
Zacks.com featured highlights include: Medifast, Shoe Carnival, Marine Products, Amedisys and NVR
Avon Teams Up With HCL Technologies to Boost Digital Growth
by Zacks Equity Research
Avon (AVP) partners with HCL Technologies to support the digital transformation of its business.
Bet Big on DuPont Analysis With These Top 5 Picks
by Sanghamitra Saha
Do you have more faith in DuPont analysis than a simple ROE calculation? Bet on these five stocks then.
The Zacks Analyst Blog Highlights: Malibu Boats, MEDIFAST, OptimizeRx, Synergy Resources and Pioneer Natural
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Malibu Boats, MEDIFAST, OptimizeRx, Synergy Resources and Pioneer Natural
Brokers Just Love These 5 Stocks
by Sejuti Banerjea
Here are 5 stocks you should buy right now.
Newell Loses 22% YTD: Can Its Transformation Plan Aid Stock?
by Zacks Equity Research
Newell's (NWL) dismal sales surprise trend can be attributed to lower core sales and adverse foreign currency. Nevertheless, its Transformation Plan appears encouraging.
4 Fitness Stocks to Buy This Summer
by Zacks Equity Research
Growing consumer preference for a healthy lifestyle could boost America's fitness industry.
Avon (AVP) Rallies 42% in 3 Months: What's Aiding the Stock?
by Zacks Equity Research
Avon (AVP) progresses well on its 'Open Up Avon' strategy. Also, the company remains committed to attain its long-term financial targets.
Consumer Beauty Hurts Coty: Can Efforts Revive Lost Sheen?
by Zacks Equity Research
Coty's (COTY) Consumer Beauty unit struggles against soft organic sales. Also, supply-chain disruptions are a drag.
Newell to Sell USPC Business, Transformation Plan on Track
by Zacks Equity Research
Newell (NWL) agrees to divest the United States Playing Card Company to Cartamundi Group. This move is in sync with the company's Transformation Plan.
Smucker's (SJM) Q4 Earnings Top Estimates, Buyout Boosts Sales
by Zacks Equity Research
Smucker's (SJM) top and bottom lines improve during Q4. Performance gains from the Ainsworth buyout, while the divestiture of the U.S. baking business is a drag.
Will Archer Daniels' Strategic Growth Efforts Drive Stock?
by Zacks Equity Research
Archer Daniels' (ADM) soft Carbohydrate Solutions segment is concerning. Nevertheless, the company's growth efforts such as the Readiness program are commendable.